Skip to content

Acceptance-Based Treatment for Generalized Anxiety Disorder

Developing a New Therapy for GAD: Acceptance-Based CBT

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00073632
Enrollment
50
Registered
2003-12-03
Start date
2002-05-31
Completion date
2006-08-31
Last updated
2013-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Disorders, Generalized Anxiety Disorder

Brief summary

This study will develop and implement an awareness- and acceptance-based for treatment of individuals with generalized anxiety disorder.

Detailed description

Participants in this study are recruited from intakes at the Center for Anxiety and Related Disorders at Boston University. Participants will be randomly assigned to receive either acceptance and mindfulness-based strategies plus cognitive behavioral therapy or no treatment for 16 weeks. The treatment will involve daily practice of mindfulness techniques to help draw attention to and accept various emotional states. Interviews, questionnaires, and depression and anxiety scales will be used to assess participants. Assessments will be conducted post-treatment and at 3- and 9-month follow-up visits.

Interventions

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
University of Massachusetts, Boston
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Generalized Anxiety Disorder (GAD) * Willing to maintain medication levels and refrain from any additional psychosocial treatment during the course of the study

Exclusion criteria

* Bipolar disorder, psychotic disorder, or substance dependence

Design outcomes

Primary

MeasureTime frame
Penn State Worry Questionnairepre-, post-, 3 mo. f/u, 9 mo. f/u
Clinician Severity Rating from ADIS for GADpre, post, 3 mo. f/u, 9 mo. f/u
Depression Anxiety and Stress Scales, anxiety and stress subscalespre-, post-, 3 mo. f/u, 9 mo. f/u

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026